摘要
目的评价三维适形放射治疗(3DCRT)对原发性肝癌的疗效,探讨其预后影响因素。方法对283例原发性肝癌患者进行3DCRT,肿瘤剂量(51.85±6.55)Gy,每次分割剂量(4.55±1.02)Gy,照射次数(10±4)次,每周3次,隔日1次。结果原发性肝癌3DCRT总有效率(CR+PR)为47.35%(134/283),1、3、5年总生存率分别为57.0%、29.0%和18.0%,性别、CLIP分期、GTV、PVTT和Child-Pugh分级对预后影响的差异有统计学意义(P均<0.01),性别、GTV、PVTT和Child-Pugh分级是独立的预后因素(P=0.008、0.007、0.006和0.003)。结论性别、GTV、PVTT和Child-Pugh分级是影响原发性肝癌3DCRT独立的预后因素。
Objective To evaluate the efficacy of three-dimensional conformal radiotherapy(3DCRT)to treat primary liver cancer (PLC)and investigate the prognostic factors associated with its use. Methods PLC patients(n = 283)were treated with 3DCRT using a total dose of 51.85±6.55 Gy(4.55±1.02 Gy/fraetion,3 fractions/week, 10±4 total fractions). Results The response rate(CR+PR)was 47.35%( 134/283 ).The 1-, 3-, and 5-year overall survival rates were 57.0%, 29.0% and 18.0%, respectively.Gender, CLIP stage, GTV, PVTT and Child-Pugh class were found to significantly affect overall survival(P〈0.01 ).Independent prognostic factors were gender (P=0.008), GTV (P=0.007), PVTT (P=0.006)and Child-Pugh class (P=0.003).Conclusion Gender, GTV, PVTT and Child-Pugh class may be independent prognostic factors when using 3DCRT to treat PLC.
出处
《中国癌症防治杂志》
CAS
2012年第2期163-166,共4页
CHINESE JOURNAL OF ONCOLOGY PREVENTION AND TREATMENT
基金
广西卫生厅重点科研课题(重2010071)
关键词
肝肿瘤
三维适形放射治疗
预后
Liver neoplasms
Three-dimensional conformal radiotherapy
Prognosis